Fukuzawa Ryuji, Breslow Norman E, Morison Ian M, Dwyer Patrick, Kusafuka Takeshi, Kobayashi Yasutsugu, Becroft David M, Beckwith J Bruce, Perlman Elizabeth J, Reeve Anthony E
Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Lancet. 2004 Feb 7;363(9407):446-51. doi: 10.1016/S0140-6736(04)15491-3.
Variations in the international incidence of Wilms' tumour might be due to genetic factors. The maternal insulin-like growth factor 2 gene (IGF2) is imprinted in normal tissues, whereas in some Wilms' tumours and other tumour types the imprint is lost, leading to biallelic transcription of IGF2. We investigated whether the difference in incidence of Wilms' tumour between children of east-Asian descent and white children is due to variations in proportion of tumours with loss of IGF2 imprinting (IGF2 LOI).
We assessed IGF2 LOI by use of an ApaI polymorphism in IGF2 exon 9 or quantitative PCR measuring DNA methylation of the H19 and KvDMR1 alleles. The frequencies of perilobar nephrogenic rests associated with Wilms' tumour were assessed histologically in Japanese children and children of white and east-Asian descent.
IGF2 LOI was present in Wilms' tumours from predominantly white children from New Zealand (13 of 41 tumours) but absent in tumours from Japanese children (0 of 21 tumours; difference in proportions 0.32, 95% CI 0.07-0.52). Frequency of perilobar nephrogenic rests accompanying tumours from white American children (1192 of 5002, 24%) was significantly higher than in Japanese (one of 56, 1%, difference in proportions 0.22, 95% CI 0.14-0.25) and east-Asian American children (seven of 92, 8%, 0.16, 0.09-0.21).
Wilms' tumours in the east-Asian population rarely arise from the IGF2 LOI mechanism frequently noted in white patients. Our findings that IGF2 LOI and perilobar nephrogenic rests associated with this mechanism arise at low frequency in Japanese and east-Asian American children lend support to this conclusion. Variation in frequency of this epigenetic mechanism provides one explanation for the difference in incidence of Wilms' tumour between populations.
肾母细胞瘤国际发病率的差异可能归因于遗传因素。母体胰岛素样生长因子2基因(IGF2)在正常组织中呈印记状态,而在一些肾母细胞瘤及其他肿瘤类型中,该印记会丢失,导致IGF2双等位基因转录。我们研究了东亚裔儿童与白人儿童肾母细胞瘤发病率的差异是否源于IGF2印记丢失(IGF2 LOI)肿瘤比例的不同。
我们通过检测IGF2外显子9中的ApaI多态性或定量PCR测定H19和KvDMR1等位基因的DNA甲基化来评估IGF2 LOI。组织学评估了日本儿童以及白人和东亚裔儿童中与肾母细胞瘤相关的叶周肾源性残留的频率。
来自新西兰的主要为白人儿童的肾母细胞瘤中存在IGF2 LOI(41例肿瘤中有13例),而日本儿童的肿瘤中不存在IGF2 LOI(21例肿瘤中有0例;比例差异为0.32,95%可信区间为0.07 - 0.52)。美国白人儿童肿瘤伴随的叶周肾源性残留频率(5002例中有1192例,24%)显著高于日本儿童(56例中有1例,1%,比例差异为0.22,95%可信区间为0.14 - 0.25)和美国东亚裔儿童(92例中有7例,8%,0.16,0.09 - 0.21)。
东亚人群中的肾母细胞瘤很少源于白人患者中常见的IGF2 LOI机制。我们的研究结果表明,在日本和美国东亚裔儿童中,与该机制相关的IGF2 LOI和叶周肾源性残留出现频率较低,支持了这一结论。这种表观遗传机制频率的差异为不同人群中肾母细胞瘤发病率的差异提供了一种解释。